When symptoms clearly follow herpes outbreaks, antiviral suppression may also be considered
Semaglutide (commonly recognized by brands like Wegovy and Ozempic) and Tirzepatide (Mounjaro) are part of a class of medications known as GLP-1 receptor agonists

Why women need lower doses Biological differences: Smaller average body size Different hormone profiles More sensitive to some peptides Better response at lower doses often General rule: Start 20-30% lower than male doses Women: 150-200mcg vs Men: 200-300mcg (GH peptides) Titrate based on response More isn't better for women Hormone cycle considerations (perimenopause) If still menstruating: GH peptides: Use consistently throughout cycle Weight loss peptides: May work better in follicular phase (days 1-14) Some women dose higher during luteal phase (more resistant) Track response across full cycle Post-menopause: No cycle to consider Consistent dosing easier More predictable results Age-specific dosing Women 40-50 (perimenopause): Start conservative Body still producing some hormones Lower doses effective Women 50-60 (menopause): Standard doses appropriate Need more GH replacement Can titrate higher if needed Women 60-70+: Start very low Increase slowly More sensitive to side effects Benefits still significant Safety considerations for women over 40 Special precautions for this demographic

If your blood sugar levels are still high, your dose may gradually increase to 7.5 mg, 10 mg, 12.5 mg, or 15 mg
your prescriber will review your medical history, including stomach, kidney, liver, pancreas, eye and gallbladder problems, to ensure Wegovy is safe and appropriate for you
Hydroxocobalamin is longer-acting , more bioavailable , and less toxic than cyanocobalamin